Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 372

Related Citations for PubMed (Select 12695317)

1.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.

Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J; Lamictal 606 Study Group.

Arch Gen Psychiatry. 2003 Apr;60(4):392-400. Erratum in: Arch Gen Psychiatry. 2004 Jul;61(7):680.

PMID:
12695317
2.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1013-24.

PMID:
14628976
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

Spotlight on lamotrigine in bipolar disorder.

Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM.

CNS Drugs. 2004;18(1):63-7.

PMID:
14731061
5.

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R.

J Clin Psychiatry. 2004 Mar;65(3):432-41.

PMID:
15096085
6.

Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.

Goldberg JF, Calabrese JR, Saville BR, Frye MA, Ketter TA, Suppes T, Post RM, Goodwin FK.

J Clin Psychiatry. 2009 Sep;70(9):1273-80. doi: 10.4088/JCP.08m04381. Epub 2009 Aug 11.

PMID:
19689918
7.

Lamotrigine: a review of its use in bipolar disorder.

Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM.

Drugs. 2003;63(19):2029-50. Review.

PMID:
12962521
8.

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.

Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL.

Am J Psychiatry. 2005 Nov;162(11):2152-61.

PMID:
16263857
9.

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.

Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ.

Arch Gen Psychiatry. 2000 May;57(5):481-9.

PMID:
10807488
10.

A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.

Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET.

J Clin Psychiatry. 2000 Nov;61(11):841-50.

PMID:
11105737
11.

Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).

Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B; Trial 144 Study Investigators.

J Clin Psychiatry. 2011 Nov;72(11):1452-64. doi: 10.4088/JCP.11m06878. Erratum in: J Clin Psychiatry. 2014 Mar;75(3):290.

PMID:
22054050
12.

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M.

J Clin Psychiatry. 2006 Jan;67(1):95-101.

PMID:
16426094
13.

Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.

Calabrese JR, Goldberg JF, Ketter TA, Suppes T, Frye M, White R, DeVeaugh-Geiss A, Thompson TR.

Biol Psychiatry. 2006 Jun 1;59(11):1061-4.

PMID:
16769295
14.

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD.

J Clin Psychiatry. 1999 Feb;60(2):79-88.

PMID:
10084633
15.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.

Am J Psychiatry. 2005 Jul;162(7):1281-90.

PMID:
15994710
16.

Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder.

Khan A, Ginsberg LD, Asnis GM, Goodwin FK, Davis KH, Krishnan AA, Adams BE.

J Clin Psychiatry. 2004 Nov;65(11):1483-90.

PMID:
15554760
17.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

18.

A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.

Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, Findling RL, Calabrese JR.

J Clin Psychiatry. 2009 Jan;70(1):113-21. Epub 2008 Dec 30.

19.

Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.

Kemp DE, Gao K, Fein EB, Chan PK, Conroy C, Obral S, Ganocy SJ, Calabrese JR.

Bipolar Disord. 2012 Nov;14(7):780-9. doi: 10.1111/bdi.12013.

20.

Bipolar rapid cycling: focus on depression as its hallmark.

Calabrese JR, Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, Kimmel SE, Caban SJ.

J Clin Psychiatry. 2001;62 Suppl 14:34-41. Review.

PMID:
11469674
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk